(Q35119212)

6 August 2017

1 reference

title

Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model (English)

1 reference

6 August 2017

Possible Mechanisms of Protection Elicited by Candidate Rotavirus Vaccines as Determined with the Adult Mouse Model (English)

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

29 December 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725685

29 December 2023

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

29 December 2023

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

29 December 2023

author name string

Richard L. Ward

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725685

29 December 2023

language of work or name

1 reference

1 January 2003

1 reference

full work available at URL

6 August 2017

https://www.liebertpub.com/doi/pdf/10.1089/088282403763635410

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

29 December 2023

1 reference

6 August 2017

16

1 reference

6 August 2017

1

1 reference

6 August 2017

17-24

1 reference

A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

6 August 2017

1

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children

29 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine

29 December 2023

3

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

29 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations

29 December 2023

6

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

29 December 2023

7

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

29 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group

29 December 2023

9

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Intussusception among infants given an oral rotavirus vaccine

29 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

29 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants

29 December 2023

13

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Clinical trials of live oral rotavirus vaccines: the Finnish experience

29 December 2023

14

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

29 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

29 December 2023

16

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants

29 December 2023

17

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Prolonged efficacy of rhesus rotavirus vaccine in Swedish children

29 December 2023

18

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population

29 December 2023

19

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Field trial of rhesus rotavirus vaccine in infants

29 December 2023

20

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine

29 December 2023

21

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

29 December 2023

22

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

29 December 2023

23

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

29 December 2023

24

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Role of coproantibody in clinical protection of children during reinfection with rotavirus

29 December 2023

25

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Fecal antibody responses to symptomatic and asymptomatic rotavirus infections

29 December 2023

26

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group

29 December 2023

27

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Rotavirus-Specific Helper T Cell Responses in Newborns, Infants, Children, and Adults

29 December 2023

28

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection

29 December 2023

29

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults

29 December 2023

30

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity

29 December 2023

31

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.

29 December 2023

32

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.

29 December 2023

33

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs

29 December 2023

34

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Development of an adult mouse model for studies on protection against rotavirus

29 December 2023

35

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody

29 December 2023

36

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination

29 December 2023

37

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

29 December 2023

38

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.

29 December 2023

39

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Relative importance of rotavirus-specific effector and memory B cells in protection against challenge.

29 December 2023

40

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice

29 December 2023

41

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice

29 December 2023

42

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.

29 December 2023

44

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model

29 December 2023

45

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

29 December 2023

46

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins

29 December 2023

47

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea.

29 December 2023

48

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice.

29 December 2023

49

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities

29 December 2023

50

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

29 December 2023

51

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

Functional mapping of protective domains and epitopes in the rotavirus VP6 protein

29 December 2023

52

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

29 December 2023

53

1 reference

https://api.crossref.org/works/10.1089/088282403763635410

29 December 2023

Identifiers

1 reference

6 August 2017

1 reference